Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?

M Del Re, V Citi, S Crucitta, E Rofi, F Belcari, Ron van Schaik, R Danesi

Clinical Chemistry

Research output: Contribution to journal › Article › Academic › peer-review

33 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	398-406
Number of pages	9
Journal	Pharmacological Research
Volume	107
DOIs	https://doi.org/10.1016/j.phrs.2016.03.025
Publication status	Published - 2016

Research programs

EMC MM-01-25-01

Access to Document

10.1016/j.phrs.2016.03.025

Cite this

@article{3c538cbc55e84ddf9607e848da8920f8,

title = "Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?",

author = "{Del Re}, M and V Citi and S Crucitta and E Rofi and F Belcari and {van Schaik}, Ron and R Danesi",

year = "2016",

doi = "10.1016/j.phrs.2016.03.025",

language = "Undefined/Unknown",

volume = "107",

pages = "398--406",

journal = "Pharmacological Research",

issn = "1043-6618",

publisher = "Academic Press",

}

TY - JOUR

T1 - Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?

AU - Del Re, M

AU - Citi, V

AU - Crucitta, S

AU - Rofi, E

AU - Belcari, F

AU - van Schaik, Ron

AU - Danesi, R

PY - 2016

Y1 - 2016

U2 - 10.1016/j.phrs.2016.03.025

DO - 10.1016/j.phrs.2016.03.025

M3 - Article

C2 - 27060675

SN - 1043-6618

VL - 107

SP - 398

EP - 406

JO - Pharmacological Research

JF - Pharmacological Research

ER -